ATLANTA — Moderna’s respiratory syncytial virus vaccine is safe and effective for adults who have received a solid organ ...

Moderna, Inc. (NASDAQ:MRNA) today announced that the first patient has been dosed in a Phase 1/2 study of mRNA-2808, the ...

"The CRISPR technology was introduced as an mRNA," Coller said. "That is the critical feature ... The cuts are sending ...

"Report Uncovers Key Trends, Disease Insights and Clinical Trials Shaping the Future of the Global mRNA Therapeutics Market"Boston, Oct. 29, 2025 (GLOBE NEWSWIRE) -- According to the latest study from ...

Messenger RNA (mRNA) therapeutics hold significant promise for the future of personalized cancer treatment, but persistent ...

Scientists have developed an experimental mRNA vaccine that, when combined with existing immunotherapy drugs, could 'teach' ...

Additionally, SK Bioscience has submitted a domestic phase 3 clinical trial plan (IND) to the Ministry of Food and Drug Safety to add a two-dose indication ... Based on this, SK Bioscience aims to ...

Utilizes human LINE-1 machinery to drive programmable, site-specific integration of multi-kb payloads, without ...

The Needle-Free Injection System Market represents a groundbreaking advancement in medical technology, offering an innovative alternative to traditional needle-based drug delivery methods. These ...

Hanmi Pharmaceutical, the core business subsidiary of Hanmi Science, unveiled a range of next-generation modality research achievements at a ...

Melbourne researchers have developed a new RNA drug designed to prevent the damaging effects of the debilitating autoimmune disease lupus, in a major ...

By: DANNY QUAH Can adversarial nations work together for the common good? It’s natural to despair over prospects for international cooperation given the state of the world order. Geopolitical ...